VYGR
Voyager Therapeutics, Inc.
Nasdaq Biological Products, (No Diagnostic Substances) Accelerated filer

Key Financials

Net Income
$-119721000
↓ 84.2%
Revenue
$40.4M
↓ 49.5%
Total Assets
$252.3M
↓ 35.8%
Operating Income
$-131844000
↓ 58.3%
Shareholders' Equity
$196.1M
↓ 34.6%
EPS (Diluted)
$-2.04
↓ 80.5%
Total Liabilities
$56.2M
↓ 39.8%
Cash & Equivalents
$65.3M
↓ 8.5%

Recent SEC Filings

Form Type Filed Date Link
PRE 14A 4/10/2026 View on SEC
4 4/3/2026 View on SEC
4 4/3/2026 View on SEC
144 4/2/2026 View on SEC
SCHEDULE 13G/A 3/27/2026 View on SEC
8-K 3/9/2026 View on SEC
10-K 3/9/2026 View on SEC
4 2/26/2026 View on SEC
4 2/26/2026 View on SEC
4 2/26/2026 View on SEC

Company Information

Field Value
Ticker VYGR
Company Name Voyager Therapeutics, Inc.
CIK 1640266
Sector Biological Products, (No Diagnostic Substances)
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 857-259-5340